- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 497242, 8 pages
Assessment of Anticholinesterase Activity of Gelidiella acerosa: Implications for Its Therapeutic Potential against Alzheimer’s Disease
Department of Biotechnology, Alagappa University, Tamil Nadu, Karaikudi 630 003, India
Received 19 August 2012; Revised 8 October 2012; Accepted 25 October 2012
Academic Editor: Andrew Scholey
Copyright © 2012 Arif Nisha Syad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. L. Cummings, H. V. Vinters, G. M. Cole, and Z. S. Khachaturian, “Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities,” Neurology, vol. 51, no. 1, pp. S2–S17, 1998.
- R. D. Terry and R. Katzman, “Senile dementia of the Alzheimer type,” Annals of Neurology, vol. 14, no. 5, pp. 497–506, 1983.
- M. Irizarry and B. Hyman, “Alzheimer’s disease,” in Principles of Neuroepidemiology, T. Batchlor and M. Cudkowicz, Eds., pp. 69–98, Butterworth-Heinemann, Boston, Mass, USA, 2001.
- J. C. Jaén, V. E. Gregor, C. Lee, R. Davis, and M. Emmerling, “Acetylcholinesterase inhibition by fused dihydroquinazoline compounds,” Bioorganic and Medicinal Chemistry Letters, vol. 6, no. 6, pp. 737–742, 1996.
- L. S. Schneider, “New therapeutic approaches to Alzheimer's disease,” Journal of Clinical Psychiatry, vol. 57, supplement 14, pp. 30–36, 1996.
- S. Darvesh, R. Walsh, R. Kumar et al., “Inhibition of human cholinesterases by drugs used to treat Alzheimer disease,” Alzheimer Disease and Associated Disorders, vol. 17, no. 2, pp. 117–126, 2003.
- V. Zarotsky, J. J. Sramek, and N. R. Cutler, “Galantamine hydrobromide: an agent for Alzheimer's disease,” American Journal of Health-System Pharmacy, vol. 60, no. 5, pp. 446–452, 2003.
- D. J. McHugh, “A guide to seaweed industry,” FAO Fisheries Technical Paper no. 441, FAO, Rome, Italy, 2003.
- K. Hayashi, J. Mori, H. Saito, and T. Hayashi, “Antiviral targets of a chromene derivative from Sargassum micracanthum in the replication of human cytomegalovirus,” Biological and Pharmaceutical Bulletin, vol. 29, no. 9, pp. 1843–1847, 2006.
- P. F. Dias, J. M. Siqueira, L. F. Vendruscolo et al., “Antiangiogenic and antitumoral properties of a polysaccharide isolated from the seaweed Sargassum stenophyllum,” Cancer Chemotherapy and Pharmacology, vol. 56, no. 4, pp. 436–446, 2005.
- K. Prasad, A. K. Siddhanta, M. Ganesan, B. K. Ramavat, B. Jha, and P. K. Ghosh, “Agars of Gelidiella acerosa of west and southeast coasts of India,” Bioresource Technology, vol. 98, no. 10, pp. 1907–1915, 2007.
- G. A. S. Premakumara, W. D. Ratnasooriya, L. M. V. Tillekeratne, A. S. Amarasekare, and A. U. Rahman, “Human sperm motility stimulating activity of a sulfono glycolipid isolated from Sri Lankan marine red alga Gelidiella acerosa,” Asian Journal of Andrology, vol. 3, no. 1, pp. 27–31, 2001.
- G. A. S. Premakumara, W. D. Ratnasooriya, and L. M. V. Tillekeratne, “Isolation of a non-steroidal contragestative agent from Sri Lankan marine red alga, Gelidiella acerosa,” Contraception, vol. 54, no. 6, pp. 379–383, 1996.
- K. P. Devi, N. Suganthy, P. Kesika, and S. K. Pandian, “Bioprotective properties of seaweeds: in vitro evaluation of antioxidant activity and antimicrobial activity against food borne bacteria in relation to polyphenolic content,” BMC Complementary and Alternative Medicine, vol. 8, article 38, 2008.
- R. M. Oza and A. Zaidu, Revised Checklist of Indian Marine Alage, Central Salt and Marine Chemicals Research Institute, Bhavnagar, India, 2003.
- V. Krishnamurthy and H. Y. Joshi, A Check List of Indian Marine Algae, Central Salt and Marine Chemicals Research Institute, Bhavnagar, India, 1970.
- G. L. Ellman, K. D. Courtney, V. Andres, and R. M. Featherstone, “A new and rapid colorimetric determination of acetylcholinesterase activity,” Biochemical Pharmacology, vol. 7, no. 2, pp. 88–95, 1961.
- K. Ingkaninan, C. M. De Best, R. Van Der Heijden et al., “High-performance liquid chromatography with on-line coupled UV, mass spectrometric and biochemical detection for identification of acetylcholinesterase inhibitors from natural products,” Journal of Chromatography A, vol. 872, no. 1-2, pp. 61–73, 2000.
- G. E. Trease and W. C. Evans, Pharmacognosy, Bailliere Tindall, London, UK, 13th edition, 1989.
- A. Sofowora, Medicinal Plants and Traditional Medicine in Africa, Spectrum Books, Ibadan, Nigeria, 1993.
- J. B. Harborne, Phytochemical Methods, Chapman and Hall, London, UK, 1973.
- J. B. Harborne, Phytochemical Methods- A Guide to Modern Techniques of Plant Analysis, Chapman and Hall, London, UK, 1980.
- H. Wagner, S. Bladt, and E. M. Zygainski, Plant Drug Analysis- A Thin Layer Chromatography Atlas, Springer, Berlin, Germany, 1984.
- S. H. Karmarkar, R. Keshavachandran, and A. Augustin, “Biochemical evaluation of root tubers and in vitro induced callus of adapathiyan (HOLOSTEMMA ADA-KODIEN K. SCHUM.),” Journal of Tropical Agriculture, vol. 39, pp. 108–110, 2001.
- T. Benie and M. L. Thieulant, “Interaction of some traditional plant extracts with uterine oestrogen or progestin receptors,” Phytotherapy Research, vol. 17, no. 7, pp. 756–760, 2003.
- J. Balzarini, A. I. Hernández, P. Roche et al., “Non-nucleoside inhibitors of mitochondrial thymidine kinase (TK-2) differentially inhibit the closely related herpes simplex virus type 1 TK and Drosophila melanogaster multifunctional deoxynucleoside kinase,” Molecular Pharmacology, vol. 63, no. 2, pp. 263–270, 2003.
- E. Giacobini, “Drugs that target cholinesterase,” in Cognitive Enhancing Drugs, J. J. Buccafusco, Ed., pp. 11–36, Birkhäuser, Basel, Switzerland, 2004.
- J. R. Hodges, “Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects,” Brain, vol. 129, no. 11, pp. 2811–2822, 2006.
- M. Zimmermann, F. Gardoni, E. Marcello et al., “Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines,” Journal of Neurochemistry, vol. 90, no. 6, pp. 1489–1499, 2004.
- N. H. Greig, T. Utsuki, Q. S. Yu et al., “A new therapeutic target in Alzheimer's disease treatment: attention to butyryloholinesterase,” Current Medical Research and Opinion, vol. 17, no. 3, pp. 159–165, 2001.
- P. K. Mukherjee, V. Kumar, M. Mal, and P. J. Houghton, “Acetylcholinesterase inhibitors from plants,” Phytomedicine, vol. 14, no. 4, pp. 289–300, 2007.
- F. Menichini, R. Tundis, M. R. Loizzo et al., “Acetylcholinesterase and butyrylcholinesterase inhibition of ethanolic extract and monoterpenes from Pimpinella anisoides V Brig. (Apiaceae),” Fitoterapia, vol. 80, no. 5, pp. 297–300, 2009.
- H. J. Chang, H. J. Kim, and H. S. Chun, “Quantitative structure-activity relationship (QSAR) for neuroprotective activity of terpenoids,” Life Sciences, vol. 80, no. 9, pp. 835–841, 2007.
- L. Mu, J. Kou, D. Zhu, and B. Yu, “Comparison of neuroprotective effects of flavonoids, terpenoids, and their combinations from Ginkgo biloba on ischemia-reperfusion—injured mice,” Pharmaceutical Biology, vol. 45, no. 9, pp. 728–733, 2007.
- I. Kivrak, M. E. Duru, M. Öztürk, N. Mercan, M. Harmandar, and G. Topçu, “Antioxidant, anticholinesterase and antimicrobial constituents from the essential oil and ethanol extract of Salvia potentillifolia,” Food Chemistry, vol. 116, no. 2, pp. 470–479, 2009.
- K. Shiomi, “Meroterpenoids with various biological activities produced by fungi,” Pure and Applied Chemistry, vol. 71, no. 6, pp. 1059–1064, 1999.
- S. U. Savelev, E. J. Okello, and E. K. Perry, “Butyryl- and acetylcholinesterase inhibitory activities in essential oils of Salvia species and their constituents,” Phytotherapy Research, vol. 18, no. 4, pp. 315–324, 2004.